Bank of America Corp DE Cuts Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Bank of America Corp DE lessened its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 86.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 98,462 shares of the company's stock after selling 652,958 shares during the quarter. Bank of America Corp DE owned about 0.11% of Acadia Healthcare worth $3,904,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Lindbrook Capital LLC lifted its position in shares of Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after buying an additional 671 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after acquiring an additional 301 shares during the period. Signaturefd LLC raised its position in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp raised its position in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after purchasing an additional 454 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Royal Bank of Canada reduced their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Bank of America reduced their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Mizuho reduced their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Finally, Guggenheim assumed coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded up $0.81 on Tuesday, reaching $22.44. 1,967,727 shares of the company were exchanged, compared to its average volume of 1,722,242. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41. The firm has a market cap of $2.07 billion, a price-to-earnings ratio of 7.36, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a 50-day moving average of $24.78 and a 200-day moving average of $34.04.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analysts' expectations of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm's revenue was up .3% on a year-over-year basis. During the same period in the prior year, the company earned $0.84 EPS. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.